The United States will continue to press for a waiver of intellectual property rights for Covid-19 vaccines and treatments even as it and other Group of Seven rich nations sharply expand donations of vaccines to poorer countries.
The United States on June 10 raised the pressure on other Group of Seven (G7) leaders to share their vaccine hoards to bring an end to the pandemic by pledging to donate 500 million doses of the Pfizer coronavirus vaccine to the world’s poorest countries.
2020 was a challenging year in more ways than one, and many agencies acknowledged those hardships in holiday cards and video messages. One agency took a slightly different approach: CDM New York created their own eBay page to auction off “The Year 2020” at a starting price of a single penny.
Gilead Sciences Inc., maker of the closely watched experimental coronavirus drug remdesivir, said the company will work with international partners to expand production of the potential COVID-19 treatment.
In response to calls for personal protective equipment for health care workers and other front-line responders battling the COVID-19 pandemic, Merck & Co. Inc. is donating 300,000 masks to New Jersey’s Office of Homeland Security and Preparedness. Merck already donated 500,000 masks for use in New York City.
Gilead Sciences Inc. announced that the company will donate Truvada for PrEP (emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg tablets) to the U.S. CDC.
Donating billions of dollars to global funds that fight poverty and disease is one of the best investments governments can make to boost security and economic growth, philanthropists Bill and Melinda Gates said.
Illinois-based AbbVie donated $100 million to Ronald McDonald House Charities (RMHC).
As the CEO of a nonprofit that greatly depends on support from both corporations and individuals, I appreciate companies that donate their products and services to medical relief and development international NGOs like ours. A large part of our success is the result of relationships we’ve built with the nation’s leading pharmaceutical companies, including Johnson & Johnson, Abbott, AbbVie and Merck.
Sanofi Genzyme has agreed to begin donating materials to create an extensive archival collection to the Historical Collections of Harvard Business School’s Baker Library.